Chemed Corporation $CHE Stake Cut by DRH Investments Inc.

Posted by Brenda Bartman on Jun 14th, 2026

DRH Investments Inc. decreased its stake in shares of Chemed Corporation (NYSE:CHE – Free Report) by 8.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 19,155 shares of the company’s stock after selling 1,820 shares during the period. Chemed accounts for 7.5% of DRH Investments Inc.’s portfolio, making the stock its 8th largest position. DRH Investments Inc.’s holdings in Chemed were worth $8,196,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the stock. Entropy Technologies LP lifted its holdings in Chemed by 35.1% during the 4th quarter. Entropy Technologies LP now owns 1,216 shares of the company’s stock worth $520,000 after purchasing an additional 316 shares in the last quarter. Epoch Investment Partners Inc. lifted its holdings in Chemed by 4.9% during the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock worth $137,945,000 after purchasing an additional 15,133 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in Chemed by 61.7% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 154,519 shares of the company’s stock worth $66,112,000 after purchasing an additional 58,946 shares in the last quarter. Aptus Capital Advisors LLC lifted its holdings in Chemed by 1.3% during the 4th quarter. Aptus Capital Advisors LLC now owns 57,381 shares of the company’s stock worth $24,551,000 after purchasing an additional 757 shares in the last quarter. Finally, FORA Capital LLC purchased a new stake in Chemed during the 4th quarter worth about $795,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Oppenheimer lowered their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Finally, Royal Bank Of Canada raised their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, Chemed presently has an average rating of “Hold” and an average target price of $501.50.

Read Our Latest Report on CHE

Chemed Stock Performance

NYSE:CHE opened at $419.07 on Friday. The business’s 50-day moving average price is $415.27 and its two-hundred day moving average price is $424.51. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $562.77. The stock has a market cap of $5.56 billion, a P/E ratio of 22.84, a PEG ratio of 1.57 and a beta of 0.54. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter last year, the firm posted $5.63 EPS. The company’s revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities analysts predict that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be issued a $0.60 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Insider Transactions at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the transaction, the director directly owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 3.33% of the company’s stock.

Chemed Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.